News Announcement

Suven Pharmaceuticals: Announcement under Regulation 30 (LODR)-Change in Management

Mr. Brain Shaughnessy has resigned from the position of Chief Commercial Officer and Senior management Personnnel of the Company effective on October 1 2024


दूसरी कैटेगरी